1. Giri RD, Ramya N, Poojitha G, et al. A review on thrombolytic therapy used in myocardial infarction (streptokinase vs tenecteplase). Int J Pharm Sci Rev Res. 2017;45(2):29–32.
3. Plotkin A, Weaver FA. Thrombolytic agents. In: Cronenwett JL, Johnston KW, editors. Rutherford’s vascular surgery and endovascular therapy. 9th ed. Philadelphia: Elsevier; 2019. p. 550–563.e4.
4. Ibanez B, James S, Agewall S, et al; ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393.
5. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). Pedoman tatalaksana sindrom koroner akut. Jakarta: PERKI; 2018. Available from: https://inaheart.org/wp-content/uploads/2021/07/Buku-ACS-2018.pdf
6. Rivera-Bou WL. Thrombolytic therapy. Medscape [Internet]. 2021. Available from: https://emedicine.medscape.com/article/811234-overview
7. Edwards Z, Nagalli S. Streptokinase. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Updated 2023 May 9. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553215/
8. PubChem. PubChem substance record for SID 349979070: 4-cyclohexylpyrrolidine-2-carboxylic acid. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004–. Available from: https://pubchem.ncbi.nlm.nih.gov/
10. MIMS Indonesia. Streptokinase. MIMS Online [Internet]. 2025. Available from: https://www.mims.com/indonesia/drug/info/streptokinase
13. Badan Pengawas Obat dan Makanan Republik Indonesia. Cek produk streptokinase [Internet]. 2022. Available from: https://cekbpom.pom.go.id/